Amphastar Pharma (AMPH) Tops Q2 EPS by 4c

Amphastar Pharma (NASDAQ: AMPH) reported Q2 Adj. EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.2 million versus the consensus estimate of $63.3 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue